CZ166793A3 - Diazinediones, optionally triazinediones, process of their preparation and pharmaceutical preparations in which they are comprised - Google Patents

Diazinediones, optionally triazinediones, process of their preparation and pharmaceutical preparations in which they are comprised Download PDF

Info

Publication number
CZ166793A3
CZ166793A3 CZ931667A CZ166793A CZ166793A3 CZ 166793 A3 CZ166793 A3 CZ 166793A3 CZ 931667 A CZ931667 A CZ 931667A CZ 166793 A CZ166793 A CZ 166793A CZ 166793 A3 CZ166793 A3 CZ 166793A3
Authority
CZ
Czechia
Prior art keywords
formula
methyl
compound
tetrazolyl
acid
Prior art date
Application number
CZ931667A
Other languages
Czech (cs)
English (en)
Inventor
Werner Dr Mederski
Dieter Dr Dorsch
Mathias Dr Oswald
Pierre Prof Dr Schelling
Norbert Dr Beier
Ingeborg Dr Lues
Klaus-Otto Dr Minck
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of CZ166793A3 publication Critical patent/CZ166793A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/08—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
    • C07D251/20—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with no nitrogen atoms directly attached to a ring carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CZ931667A 1992-08-23 1993-08-13 Diazinediones, optionally triazinediones, process of their preparation and pharmaceutical preparations in which they are comprised CZ166793A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4227773A DE4227773A1 (de) 1992-08-23 1992-08-23 Di- bzw. Triazindione

Publications (1)

Publication Number Publication Date
CZ166793A3 true CZ166793A3 (en) 1994-03-16

Family

ID=6466102

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ931667A CZ166793A3 (en) 1992-08-23 1993-08-13 Diazinediones, optionally triazinediones, process of their preparation and pharmaceutical preparations in which they are comprised

Country Status (15)

Country Link
EP (1) EP0589201A1 (OSRAM)
JP (1) JPH06184118A (OSRAM)
KR (1) KR940003941A (OSRAM)
CN (1) CN1086214A (OSRAM)
AU (1) AU4469193A (OSRAM)
CA (1) CA2104501A1 (OSRAM)
CZ (1) CZ166793A3 (OSRAM)
DE (1) DE4227773A1 (OSRAM)
HU (1) HUT70201A (OSRAM)
MX (1) MX9305076A (OSRAM)
NO (1) NO932967L (OSRAM)
PL (1) PL300165A1 (OSRAM)
SK (1) SK88493A3 (OSRAM)
TW (1) TW242620B (OSRAM)
ZA (1) ZA936135B (OSRAM)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0407342A3 (en) * 1989-07-06 1991-07-10 Ciba-Geigy Ag Pyrimidine derivatives
US5100897A (en) * 1989-08-28 1992-03-31 Merck & Co., Inc. Substituted pyrimidinones as angiotensin ii antagonists
US5162326A (en) * 1990-02-15 1992-11-10 Takeda Chemical Industries, Ltd. Pyrimidinedione derivatives, their production and use

Also Published As

Publication number Publication date
NO932967D0 (no) 1993-08-20
MX9305076A (es) 1994-04-29
SK88493A3 (en) 1994-06-08
CA2104501A1 (en) 1994-02-24
DE4227773A1 (de) 1994-02-24
TW242620B (OSRAM) 1995-03-11
ZA936135B (en) 1994-03-17
CN1086214A (zh) 1994-05-04
PL300165A1 (en) 1994-03-07
AU4469193A (en) 1994-02-24
EP0589201A1 (de) 1994-03-30
JPH06184118A (ja) 1994-07-05
KR940003941A (ko) 1994-03-14
HUT70201A (en) 1995-09-28
NO932967L (no) 1994-02-24
HU9302380D0 (en) 1993-11-29

Similar Documents

Publication Publication Date Title
ES2236178T3 (es) Nuevos compuestos de imidazolina.
EP0443568B1 (en) Fused thiophene derivatives, their production and use
US6864253B2 (en) Benzo[4,5]thieno[2,3-c]pyridine and Benzo[4,5]furo[2,3-c]pyridine Derivatives Useful as Inhibitors of Phosphodiesterase
AU757290B2 (en) Imidazolone anorectic agents: II. phenyl derivatives
ES2214633T3 (es) Arilalcanoilpiridazinas.
SK57793A3 (en) Benzimidazole derivatives process for their preparation and their pharmaceutical compositions
CZ287394A3 (en) Imadazopyridazines, process of their preparation and pharmaceutical compositions based thereon and process for preparing thereof
US5532276A (en) Imidazopyridines
CZ275893A3 (en) Imidazopyridines
CA2148260A1 (en) Quinazoline cpompounds
WO1996007641A1 (en) Heterocyclic derivative and medicine
EP0574846A2 (de) Imidazopyridine als Angiotensin II Antigonisten
US4505910A (en) Amino-pyrimidine derivatives, compositions and use
US6800625B2 (en) Substituted 2,4-dihydro-pyrrolo[3,4-b]quinolin-9-one derivatives useful as phosphodiesterase inhibitors
EP0039190A1 (en) 2-(1-Piperazinyl)-4-pyrimidinamines and related compounds
JPH10316664A (ja) 治療に有用なキノリンおよびキナゾリン化合物
CZ58193A3 (en) Derivatives of imidazopyridine, process of their preparation and pharmaceutical preparations based thereon
US5405964A (en) Imidazopyridines
JP2000119272A (ja) 新規7−アミノピリド〔2,3−d〕ピリミジン誘導体
EP0668275A1 (en) Pyrrolidinone derivatives
WO1981003022A1 (en) 2-(1-piperazinyl)-4-pyrimidinamines
SK88493A3 (en) Diazinediones, especially triazinediones, process of their production and their pharmaceutical compositions
JP2837318B2 (ja) アンジオテンシンii拮抗性ピリジン誘導体
JP2631888B2 (ja) チエノピリミジン誘導体
US20120029041A1 (en) 2-aryl imidazoline derivatives